Hematuria after renal allograft biopsy: treatment with aminocaproic acid.
Aminocaproic acid (EACA) was used in 2 patients with cadaveric renal allografts because gross hematuria developed after percutaneous renal biopsies. Marked improvement was noted within twelve hours with no recurrence after discontinuation of EACA. EACA was effective in moderate renal failure.
D000293:Adolescent; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D001707:Biopsy, Needle / Q000009:adverse effects*; D002648:Child; D006084:Graft Rejection; D006417:Hematuria / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007668:Kidney / Q000473:pathology*; D016030:Kidney Transplantation; D008297:Male; D014184:Transplantation, Homologous
D000614:Aminocaproates; D015119:Aminocaproic Acid